ExploreWatchlistsPricing
  1. US-listed companies
  2. GlobeStar Therapeutics Corp
  3. Financials
  4. Retained earnings

GlobeStar Therapeutics Corp (GSTC)

Market cap
$124.11K
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Sep 30, 2023-20+10.53%
Sep 30, 2022-19+8.74%
Sep 30, 2021-17+135.84%
Sep 30, 2020-7+8.12%
Sep 30, 2019-7+11.25%
Sep 30, 2018-6+15.76%
Sep 30, 2017-5+47.97%
Sep 30, 2016-4+6133.21%
Sep 30, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat